| The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease … S Alatab, SG Sepanlou, K Ikuta, H Vahedi, C Bisignano, S Safiri, ... The Lancet gastroenterology & hepatology 5 (1), 17-30, 2020 | 1751 | 2020 |
| The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 SG Sepanlou, S Safiri, C Bisignano, KS Ikuta, S Merat, M Saberifiroozi, ... The Lancet gastroenterology & hepatology 5 (3), 245-266, 2020 | 1238 | 2020 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 435 | 2022 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 326 | 2022 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022 | 247 | 2022 |
| SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study H Poustchi, M Darvishian, Z Mohammadi, A Shayanrad, A Delavari, ... The Lancet Infectious Diseases 21 (4), 473-481, 2021 | 178 | 2021 |
| Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa G Shiha, K Alswat, M Al Khatry, AI Sharara, N Örmeci, I Waked, ... The lancet Gastroenterology & hepatology 6 (1), 57-64, 2021 | 144 | 2021 |
| Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a … A Sadeghi, A Ali Asgari, A Norouzi, Z Kheiri, A Anushirvani, M Montazeri, ... Journal of Antimicrobial Chemotherapy 75 (11), 3379-3385, 2020 | 123 | 2020 |
| Removal of penicillin G from aqueous phase by Fe+3-TiO2/UV-A process M Dehghani, S Nasseri, M Ahmadi, MR Samaei, A Anushiravani Journal of Environmental Health Science and Engineering 12, 1-7, 2014 | 81 | 2014 |
| Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial A Anushiravani, N Haddadi, M Pourfarmanbar, V Mohammadkarimi European journal of gastroenterology & hepatology 31 (5), 613-617, 2019 | 74 | 2019 |
| Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17 KE Wiens, PA Lindstedt, BF Blacker, KB Johnson, MM Baumann, ... The Lancet Global Health 8 (8), e1038-e1060, 2020 | 45 | 2020 |
| Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results A Gandomkar, H Poustchi, M Moini, M Moghadami, H Imanieh, MR Fattahi, ... International journal of public health 62 (3), 397-406, 2017 | 44 | 2017 |
| Evaluation of the effect of nebulized N-acetylcysteine on respiratory secretions in mechanically ventilated patients: randomized clinical trial SM Masoompour, A Anushiravani, AT Norouz Iranian Journal of Medical Sciences 40 (4), 309, 2015 | 38 | 2015 |
| Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study M Sorouri, A Kasaeian, H Mojtabavi, AR Radmard, S Kolahdoozan, ... Infectious Agents and Cancer 15, 1-11, 2020 | 36 | 2020 |
| Prediction of internet addiction based on information literacy among students of Iran University of Medical Sciences M Langarizadeh, M Naghipour, SM Tabatabaei, A Mirzaei, ME Vaghar Electronic physician 10 (2), 6333, 2018 | 32 | 2018 |
| Burden of liver diseases: a review from Iran A Anushiravani, SG Sepanlou Middle East Journal of Digestive Diseases 11 (4), 189, 2019 | 30 | 2019 |
| The association between prolonged proton pump inhibitors use and bone mineral density MR Fattahi, R Niknam, M Shams, A Anushiravani, SA Taghavi, ... Risk management and healthcare policy, 349-355, 2019 | 29 | 2019 |
| Direct ex vivo effects of herbal extracts on serum bilirubin in neonatal blood samples SH Nabavizadeh, OB Majid, A Anushiravani Afr J Biochem Res 3 (5), 226-8, 2009 | 27 | 2009 |
| The prevalence of G6PD deficiency in blood transfusion recipients SH Nabavizadeh, A ANUSHlRAVANI Hematology 12 (1), 85-88, 2007 | 27 | 2007 |
| Correlation between serum ferritin level and histopathological disease severity in non-alcoholic fatty liver disease SRM Mousavi, B Geramizadeh, A Anushiravani, F Ejtehadi, MH Anbardar, ... Middle East journal of digestive diseases 10 (2), 90, 2018 | 25 | 2018 |
Reza Malekzadeh M.DProfessor of Internal Medicine ,&Gastroenterology Tehran University of Medical Sciences, Iran在 tums.ac.ir 的电子邮件经过验证
